Sex Steroid Metabolism in Human Gastric Mucosa: 17B-Hydroxysteroid Dehydrogenase Type 2 in Normal, Inflamed and Neoplastic Gastric Tissues

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3889-3897

  Oduwole, Olayiwola O ^a   Mäkinen, Johanna M ^a   Isomaa, Veli V ^a   Karttunen, Tuomo J ^a   Vihko, Pirkko T ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Estrogen; Gastric cancer; H. pylori; Short chain dehydrogenases reductases

Indexed keywords

ANDROGEN; ESTROGEN; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; PROGESTERONE; SEX HORMONE;

ADULT; AGED; ANDROGEN METABOLISM; ARTICLE; CATALYSIS; CHILD; CHRONIC GASTRITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM; ESTROGEN METABOLISM; FEMALE; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; REGENERATION; SEX DIFFERENCE; STOMACH MUCOSA; STOMACH TUMOR; STOMACH ULCER;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGED; AGED, 80 AND OVER; DUODENUM; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; ISOENZYMES; MALE; MIDDLE AGED; RNA, MESSENGER; STOMACH NEOPLASMS; UP-REGULATION;

EID: 0344874096     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the world-wide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606, 1993.
2. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
3. Stadtländer CTK-H and Waterbor JW: Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20: 2195-2208, 1999.
4. El-Rifai W and Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol 12: 128-140, 2002.
5. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735-6740, 1992.
6. Neugut A, Hayek M and Howe G: Epidemiology of gastric cancer. Semin Oncol 23: 281-291, 1996.
7. Campbell-Thompson M, Lauwers GY, Reyher KK, Cromwell J and Shiverick KT: 17β-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N′-nitrosoguanidine. Endocrinology 140: 4886-4894, 1999.
8. Drago F, Montoneri C, Varga C and Laszlo F: Dual effect of female sex steroids on drug-induced gastroduodenal ulcers in the rat. Life Sci 64: 2341-2350, 1999.
9. Messa C, Pricci M, Linsalata M, Russo F and Di Leo A: Inhibitory effect of 17β-estradiol on growth and the polyamine metabolism of a human gastric carcinoma cell line (HGC-27) Scan J Gastroenterology 34: 79-84, 1999.
10. Oduwole OO, Isomaa VV, Nokelainen PA, Stenbäck F and Vihko PT: Downregulation of estrogen-metabolizing 17β-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development. Int J Cancer 97: 1-6, 2002.
11. Peltoketo H, Luu-The V, Simard J and Adamski J: 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family: nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 23: 1-11, 1999.
12. Labrie F, Luu-The V, Lin SX, Simard J, Labrie C, El-Alfy M, Pelletier G and Belanger A: Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 25: 1-16, 2000.
13. Adamski J and Jakob FJ: A guide to 17β-hydroxysteroid dehydrogenases. J Mol Cell Endocrinol 171: 1-4, 2001.
14. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A and Stern D: An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389: 689-695, 1997.
15. Li KX, Smith RE and Krozowski ZS: Cloning and expression of a novel tissue specific 17β-hydroxysteroid dehydrogenase. Endocr Res 24: 663-667, 1998.
16. Puranen TJ, Poutanen MH, Peltoketo HE, Vihko PT and Vihko RK: Site-directed mutagenesis of the putative active site of human 17β-hydroxysteroid dehydrogenase type 1. Biochem J 304: 289-293, 1994.
17. Akinola LA, Poutanen M and Vihko R: Cloning of rat 17β -hydroxysteroid dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes. Endocrinology 137: 1572-1579, 1996.
18. Miettinen MM, Mustonen MVJ, Poutanen MH, Isomaa VV and Vihko RK: Human 17β-hydroxysteroid dehydrogenase type I and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem J 314: 839-845, 1996.
19. Ghersevich S, Poutanen M, Martikainen H and Vihko R: Expression of 17β-hydroxysteroid dehydrogenase in human granulosa cells: correlation with follicular size, cytochrome P-450 aromatase activity and oestradiol production. J Endocrinology 143: 139-150, 1994.
20. Sawetawan C, Milevich L, Word RA, Carr BR and Rainey WE: Compartmentalization of type I 17β-hydroxysteroid oxidoreductase in the human ovary. Mol Cell Endocrinol 99: 161-168, 1994.
21. Mustonen MV, Isomaa VV, Vaskivuo T, Tapanainen J, Poutanen MH, Stenbäck F, Vihko RK and Vihko PT: Human 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle. J Clin Endocrinol Metab 83: 1319-1324, 1998.
22. Miettinen M, Mustonen M, Poutanen M, Isomaa V, Wickman M, Söderqvist G, Vihko R and Vihko P: 17β-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Res Treat 57: 175-182, 1999.
23. Mäentausta O, Sormunen R, Isomaa V, Lehto V-P, Jouppila P and Vihko R: Immunohistochemical localization of 17β-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. Lab Invest 65: 582-587, 1991.
24. Puranen TJ, Kurkela RM, Lakkakorpi JT, Poutanen MH, Itäranta PV, Melis JP, Ghosh D, Vihko RK and Vihko PT: Characterization of molecular and catalytic properties of intact and truncated human 17β-hydroxysteroid dehydrogenase type 2 enzymes: Intracellular localization of the wild-type enzyme in the endoplasmic reticulum. Endocrinology 140: 3334-3341, 1999.
25. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO and Andersson S: Expression, cloning and characterization of human 17β-HSD type 2, a microsomal enzyme possessing 20a-HSD activity. J Biol Chem 268: 12964-12969, 1993.
26. Elo JP, Akinola LA, Poutanen M, Vihko P, Kyllönen AP, Lukkarinen O and Vihko R: Characterization of 17β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer 66: 37-41, 1996.
27. Andersson S and Moghrabi N: Physiology and molecular genetics of 17β-hydoxysteroid dehydrogenases. Steroids 62: 143-147, 1997.
28. English MA, Stewart PM and Hewison M: Estrogen metabolism and malignancy: analysis of the expression and function of 17β-hydroxysteroid dehydrogenases in colonic cancer. Mol Cell Endocrinol 171: 53-60, 2001.
29. Mustonen MV, Poutanen MH, Kellokumpu S, de Launoit Y, Isomaa VV, Vihko RK and Vihko PT: Mouse 17β-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts. J Mol Endocrinol 20: 67-74, 1998.
30. English MA, Hughes SV, Kane KF, Langman MJ, Stewart PM and Hewison M: Oestrogen inactivation in the colon: analysis of the expression and regulation of 17β-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer. Br J Cancer 83: 550-558, 2000.
31. English MA, Kane KF, Cruickshank N, Langman MS, Stewart PM and Hewison M: Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 84: 2080-2085, 1999.
32. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis - the updated Sydney System. Am J Surg Pathol 20: 1161-1181, 1996.
33. Peltoketo H, Isomaa V and Vihko R: Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239: 73-77, 1988.
34. Couwenhoven RI, Luo W and Snead ML: Co-localization of EGF transcripts and peptides by combined immunohistochemistry and in situ hybridization. J Histochem Cytochem 38: 1853-1857, 1990.
35. Shah KA, Deacon AJ, Dunscombe P and Price AB: Intestinal metaplasia subtyping: evaluation of Gomori's aldehyde fuchsin for routine diagnostic use. Histopathology 31: 277-283, 1997.
36. Jakobsson I: Intestinal permeability in children of different ages and with different gastrointestinal diseases. Pediatr Allergy Immunol 4: 33-39, 1993.
37. Moghrabi N, Head JR and Andersson S: Cell type-specific expression of 17β-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocrinol Metab 82: 3872-3878, 1997.
38. Härkönen P, Törn S, Kurkela R, Porvari K, Pulkka A, Lindfors A, Isomaa V and Vihko P: Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J Clin Endocrinol Metab 88: 705-712, 2003.
39. Amateau SK and McCarthy MM: A novel mechanism of dendritic spine plasticity involving estradiol-induction of prostaglandin-E2. J Neurosci 22: 8586-8596, 2002.
40. Kundu N, Yang Q, Dorsey R and Fulton AM: Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer 93: 681-686, 2001.
41. Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK and Chan FK: Cyclooxygeṅase-2 expression in Helicobacterpylori-associated premalignant and malignant gastric lesions. Am J Pathol 157: 729-735, 2000.
42. Uefuji K, Ichikura T and Mochizuki H: Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 6: 135-138, 2000.
43. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D, Taylor N, Mackinley D, de Lima E and Portilla H: Helicobacter pylori and gastric carcinoma - serum antibody prevalence in populations with contrasting cancer risks. Cancer 66: 2569-2574, 1990.
44. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR and Wald N: Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 302: 1302-1305, 1991.
45. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N and Sibley RK: Helicobacterpylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991.
46. Sipponen P, Kekki M, Haapakoski J, Ihamäki T and Siurala M: Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35: 173-177, 1985.
47. Antonioli DA: Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol 25: 994-1005, 1994.
48. Wu MS, Shun CT, Lee WC, Chen CJ, Wang HP and Lee WJ: Gastric cancer risk in relation to Helicobacterpylori infection and subtypes of intestinal metaplasia. Br J Cancer 78: 125-128, 1998.